TF and anemia (phenotype): Hepcidin concentrations have been shown to predict nonresponsiveness to oral iron therapy (41); and in combination with other iron biomarkers such as ferritin and/or transferrin, hepcidin may guide in whom and when iron-based anemia interventions may be ineffective (27, 42, 43).